Chronic Kidney Disease Is Associated With Greater Bone Marrow Adiposity
Authors:
Open Access
- 3 August 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 33 (12) , 2158-2164
Abstract
Bone marrow adiposity is associated with aging, osteoporosis, and reduced hematopoiesis, as well as anorexia nervosa, but little is known about the underlying mechanisms that affect marrow adiposity. Chronic kidney disease (CKD) may influence bone marrow adipose tissue (BMAT), possibly through loss of lean mass or higher circulating levels of sclerostin. To test these hypotheses, we investigated the cross‐sectional association between estimated glomerular filtration rate (eGFR) as a measure of kidney function and 1H‐MRS‐based measurement of vertebral BMAT (L1 to L4) in 475 older adults from the Age Gene/Environment Susceptibility (AGES)‐Reykjavik study. Mean BMAT was compared in those with eGFR >60 (n = 297) versus those with eGFR 45 to 60 (n = 120) or eGFR n = 58) using linear regression models. Participants had a mean age of 81.5 (SD 4.1) years, mean eGFR of 64.3 (SD 16.1) mL/min/1.734 cm2, mean BMAT of 54.5% (SD 8.5); 48.2% were women. In unadjusted and adjusted models (age, visit window, gender, diabetes and visceral adipose tissue), BMAT was higher in those with eGFR 60 (adjusted mean 53.8%; 95% CI, 52.8 to 54.8) (p = 0.0002). BMAT did not differ in those with eGFR 45 to 60 (adjusted mean 54.3%; 95% CI, 52.8 to 55.9) compared with those with eGFR >60 (p = 0.58). In a subgroup of participants with serum sclerostin available (n = 253), additional adjustment for sclerostin attenuated the difference in adjusted mean vertebral BMAT between those with eGFR 60 from 3.7% (p = 0.04) to 2.4% (p = 0.20). CKD stage 3b or worse was associated with greater bone marrow adiposity; this association may be partially mediated by sclerostin. © 2018 American Society for Bone and Mineral Research.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR0577819, 1R01AR065645)
- National Institutes of Health (N01‐AG‐12100)
This publication has 26 references indexed in Scilit:
- The Bone Marrow-Derived Stromal Cells: Commitment and Regulation of AdipogenesisFrontiers in Endocrinology, 2016
- Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)Clinical Journal of the American Society of Nephrology, 2016
- Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney diseaseKidney International, 2016
- Changing bone patterns with progression of chronic kidney diseaseKidney International, 2016
- Circulating Sclerostin Associated With Vertebral Bone Marrow Fat in Older Men But Not WomenThe Journal of Clinical Endocrinology & Metabolism, 2014
- Vertebral Bone Marrow Fat Associated With Lower Trabecular BMD and Prevalent Vertebral Fracture in Older AdultsThe Journal of Clinical Endocrinology & Metabolism, 2013
- Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophyJournal of Bone and Mineral Research, 2012
- A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney diseaseKidney International, 2008
- Age, Gene/Environment Susceptibility-Reykjavik Study: Multidisciplinary Applied PhenomicsAmerican Journal of Epidemiology, 2007
- Age- and sex-specific differences in the1H-spectrum of vertebral bone marrowJournal of Magnetic Resonance Imaging, 2001